Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCYP2D6: novel genomic structures and alleles
Pharmacogenetics and genomics, 09/25/09
Kramer WE et al. – Several new CYP2D6 alleles and genomic structures are described which will be useful for CYP2D6 genotyping. The findings suggest that the recombination events responsible for CYP2D6 duplications and multiplications are because of mechanisms other than interchromosomal crossover during meiosis.
Related Articles
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
Drug Metabolism and Disposition, 11/12/09
Relevance Score: 65%
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
Clinical Pharmacokinetics, 10/15/09
Relevance Score: 65%
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
Drug Metabolism and Disposition, 10/09/09
Relevance Score: 65%
Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers
Journal of Clinical Pharmacy and Therapeutics, 10/05/09
Relevance Score: 47%
Original contribution: association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
JAMA, 10/07/09
Relevance Score: 46%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/16/09
The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways
Trends in Pharmacological Sciences, 12/15/09
UGT1A10: Activity against the tobacco-specific nitrosamine, NNAL, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility
Drug Metabolism and Disposition, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor